BridgeMD
New treatment option for Artery Stenosis
Official title Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)
ClinicalTrials.gov ID: NCT07462546
What this study is testing
- What it's testing
- Carotid artery stenting (CAS) prevents stroke but carries risks of perioperative cerebral embolism. Transcranial Doppler (TCD) ultrasound can detect microemboli during CAS and may offer therapeutic benefits through ultrasound-enhanced thrombolysis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Age ≥ 40 years old;
- Patients with severe stenosis of the internal carotid artery;
- Planned for carotid artery stent;
- Modified Rankin Scale score ≤ 2;
- The subject has adequate temporal bone windows to undergo TCD, and the blood flow signal of the middle cerebral artery is detectable.;
You likely can't join if
- Comorbid conditions with severe infections or severe diseases of the liver, kidney, hematopoietic system, endocrine system, etc.;
- Occurrence of intracranial hemorrhage (cerebral parenchymal hemorrhage, subarachnoid hemorrhage, subdural/epidural hemorrhage) within 90 days prior...
- Severe hematological disorders or significant coagulation abnormalities;
- Pregnant or breastfeeding women;
- Participation in another clinical trial within the past 3 months or ongoing participation;
- Any other circumstances deemed by the investigator as unsuitable for participation in this clinical study.
See the full eligibility criteria
- Age ≥ 40 years old;
- Patients with severe stenosis of the internal carotid artery;
- Planned for carotid artery stent;
- Modified Rankin Scale score ≤ 2;
- The subject has adequate temporal bone windows to undergo TCD, and the blood flow signal of the middle cerebral artery is detectable.;
- Signed informed consent by patient or their legally authorized representative.
- Comorbid conditions with severe infections or severe diseases of the liver, kidney, hematopoietic system, endocrine system, etc.;
- Occurrence of intracranial hemorrhage (cerebral parenchymal hemorrhage, subarachnoid hemorrhage, subdural/epidural hemorrhage) within 90 days prior to enrollment;
- Severe hematological disorders or significant coagulation abnormalities;
- Pregnant or breastfeeding women;
- Participation in another clinical trial within the past 3 months or ongoing participation;
- Any other circumstances deemed by the investigator as unsuitable for participation in this clinical study.
The study team makes the final eligibility decision.
Where it's taking place
- Shenyang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenyang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.